EUVIMEDEUVIMED entdecken
Crossref

Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70–LAMP2A interaction in non‐small cell lung cancer cells

Rui-Fang Dong, Cheng-Jiao Qin, Yong Yin, Liang-Liang Han, Cheng-Mei Xiao, Kai-Di Wang, Rong-Yuan Wei, Yuan-Zheng Xia, Ling-Yi Kong

British Journal of Pharmacology · 2025-05 · 182 (10) · 2287-2309

DOI: 10.1111/bph.16165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 12.07.2023. Verfasst von Rui-Fang Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, C…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lysosomal-Associated Membrane Protein 2, HSC70 Heat-Shock Proteins, Chaperone-Mediated Autophagy. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Funds for Science and Technology Development under the Guidance of the Central Government, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University) Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Chaperone‐mediated autophagy (CMA) is a selective type of autophagy targeting protein degradation and maintains high activity in many malignancies. Inhibition of the combination of HSC70 and LAMP2A can potently block CMA. At present, knockdown of LAMP2A remains the most specific method for inhibiting CMA and chemical inhibitors against CMA have not yet been discovered. Experimental Approach Levels of CMA in non‐small cell lung cancer (NSCLC) tissue samples were confirmed by tyramide signal amplification dual immunofluorescence assay. High‐content screening was performed based on CMA activity, to identify potential inhibitors of CMA. Inhibitor targets were determined by drug affinity responsive target stability‐mass spectrum and confirmed by protein mass spectrometry. CMA was inhibited and activated to elucidate the molecular mechanism of the CMA inhibitor. Key Results Suppression of interactions between HSC70 and LAMP2A blocked CMA in NSCLC, restraining tumour growth. Polyphyllin D (PPD) was identified as a targeted CMA small‐molecule inhibitor through disrupting HSC70–LAMP2A interactions. The binding sites for PPD were E129 and T278 at the nucleotide‐binding domain of HSC70 and C‐terminal of LAMP2A, respectively. PPD accelerated unfolded protein generation to induce reactive oxygen species (ROS) accumulation by inhibiting HSC70–LAMP2A–eIF2α signalling axis. Also, PPD prevented regulatory compensation of macroautophagy induced by CMA inhibition via blocking the STX17–SNAP29–VAMP8 signalling axis. Conclusions and Implications PPD is a targeted CMA inhibitor that blocked both HSC70–LAMP2A interactions and LAMP2A homo‐multimerization. CMA suppression without increasing the regulatory compensation from macroautophagy is a good strategy for NSCLC therapy. LINKED ARTICLES This article is part of a themed issue Natural Products and Cancer: From Drug Discovery to Prevention and Therapy. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.10/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLysosomal-Associated Membrane Protein 2HSC70 Heat-Shock ProteinsChaperone-Mediated AutophagyLung NeoplasmsAntineoplastic AgentsHumansAnimalsCell Line, TumorMiceDrug DiscoveryMice, NudeAutophagyProtein Binding

Stichwörter der Autor:innen

HSC70LAMP2ANSCLCPolyphyllin Dchaperone‐mediated autophagy

Substanzen

Lysosomal-Associated Membrane Protein 2HSC70 Heat-Shock ProteinsLAMP2 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.

Förderung

  • National Natural Science Foundation of China
  • Special Funds for Science and Technology Development under the Guidance of the Central Government
  • Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University) Ministry of Education
  • Jiangsu Province Graduate Research and Practice Innovation Program
  • 'Double First-Class' University Project
  • Project 211

Zitieren

APA

Dong, R. F., Qin, C. J., Yin, Y., Han, L. L., Xiao, C. M., Wang, K. D., Wei, R. Y., Xia, Y. Z., & Kong, L. Y. (2025). Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70–LAMP2A interaction in non‐small cell lung cancer cells. British Journal of Pharmacology, 182(10), 2287-2309. https://doi.org/10.1111/bph.16165

Vancouver

Dong RF, Qin CJ, Yin Y, Han LL, Xiao CM, Wang KD, et al. Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70–LAMP2A interaction in non‐small cell lung cancer cells. British Journal of Pharmacology. 2025;182(10):2287-2309. doi:10.1111/bph.16165

BibTeX
@article{Dong2025,
  author = {Dong, Rui-Fang and Qin, Cheng-Jiao and Yin, Yong and Han, Liang-Liang and Xiao, Cheng-Mei and Wang, Kai-Di and Wei, Rong-Yuan and Xia, Yuan-Zheng and Kong, Ling-Yi},
  title = {Discovery of a potent inhibitor of chaperone‐mediated autophagy that targets the HSC70–LAMP2A interaction in non‐small cell lung cancer cells},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {10},
  pages = {2287--2309},
  doi = {10.1111/bph.16165}
}
Kostenlos starten →